eif to add to other nine biotechs, page-8

adv colltech to add to other nine biotechs The biotech sector shows no signs of running out steam and established stories are getting expensive in terms of market cap. Time to look at some new ones!

ADV Colltech is an interesting story, which has the potential to be a cashflow situation in the short term. The company has patents over a process to produce collagen in bulk from sheepskin (collagen is currently produced in bulk from beefhide, which has the problems of BSE and export quality, which using sheepskin solves), and is currently going through the hurdles of due diligence for feasibility to build the factory and begin production. The process is proven, and the customer base is already there, with indicative interest to take the product. It wont be too long till the company raises capital to get all of the above in motion. Right now it is still a smallcap, at a market cap of about $7m, but I dont think this will last long as the market is slowly waking up to this one.